GLUE CapEx to Revenue

Monte Rosa Therapeutics Inc · CapEx to Revenue

GLUE logo

GLUE CapEx to Revenue

Current (TTM)27.88%
GLUE CapEx/Revenue (0.00% → 27.88%)
High-resolution chart · PNG

GLUE capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Monte Rosa Therapeutics Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
3.8004%
5.2736%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.